When will Takeda discontinue all its other meds with unknown root causes for AEs
Is this the normal outcome for any med with these events for this population?
Could it take 15 months to destroy any and all incriminating documents.
How did they get new positions so quickly after their blundering here.
You have been robbed. We have been robbed. And the public will continue to be robbed without consequences for this charade. Bite back.
I'm afraid its probably too late to catch shorts naked on this one.
Couldn't seem to generate any real interest in a solution to affy's problem, short sellers that is.
Seems shareholders are powerless against the combined force of shorts, exchanges, market makers and a bad BOD.
Could it be, maybe, that Omontys, is just bad medicine? The "inexplicable" results of the EMERALD/PEARL clinical trials resulted in the anomaly that O was statistically significantly more morbid/deadly compared to industry standard ESAs for the healthier CKD patients not on dialysis but was not inferior to industry standard ESAs for the sicker CKD patients who were on dialysis. Don't foreget that the EMA did not approve O for the European Union because O's benefits did not outweigh its risks and the clinical data Takeda submitted in support of O might not be reliable.
You are nothing buy sour grapes longfellowsss. If anybody wanted to conspire in this market it was you who hoped to organize a short squeeze. Go look in the mirror for the reason you lost your investment in AFFY.